Blue Owl Capital to Acquire Sila Realty Trust in $2.4B Deal
Alternative asset manager Blue Owl Capital announced it will acquire health‑care REIT Sila Realty Trust for $2.4 billion, paying $30.38 per share, a 19% premium. The deal adds 137 developed properties across 65 markets to Blue Owl’s portfolio, marking the latest REIT buyout in a wave of transactions this year.
Midi Health Raises $100M in Series D Funding
US‑based women's telehealth platform Midi Health announced a $100 million Series D round, bringing its valuation to $1 billion. The funding will support scaling its AI‑driven health platform, expanding insurance coverage for 45 million women and further product development.
Cala Health Secures $50M Growth Capital From Trinity Capital
Cala Health, a California-based bioelectronic medicine company, announced it has secured $50 million in growth capital from alternative asset manager Trinity Capital. The funding will support commercial expansion and product innovation for its wearable neuromodulation therapy targeting tremor disorders. The round...
Injewelme Raises $1.2M in Funding Round Led by Temasek Trust's Catalytic Capital for Climate and Health
Singapore-based health‑tech startup injewelme announced it has closed a $1.2 million funding round, led by Temasek Trust’s Catalytic Capital for Climate and Health with participation from the Richardson Family. The capital will be used to advance its contactless health monitoring technology...
Trevi Therapeutics Raises $150M in Share Sale
Biotech company Trevi Therapeutics announced it has raised $150 million by selling shares in an underwritten offering. The capital will support the company's development pipeline and growth initiatives. The deal was announced on April 17, 2026.
Orthogon Therapeutics Secures $11M Follow‑On Funding
Orthogon Therapeutics announced the closing of a follow‑on financing round of $11 million, bringing its total capital raised to $36 million. The funds will support the continued development of its first‑in‑class drug targeting BK polyomavirus, a major cause of complications in transplant...
Roche Invests $20M in C4 Therapeutics to Advance DAC Cancer Therapy
Roche has committed $20 million to C4 Therapeutics to deepen a partnership focused on developing degrader‑antibody conjugates (DACs) for cancer treatment. The strategic investment, announced in mid‑April 2026, aims to accelerate early‑stage DAC research and could expand to a $1 billion collaboration.
Beacon Biosignals Raises over $97M in Series B Financing
Boston-based Beacon Biosignals announced an upsized Series B round, bringing total funding to over $97 million. The financing will support the company's at‑home EEG and AI‑driven analytics platform for brain monitoring. The round was reported in a 2026 article highlighting...
Jackson Health Foundation Raises $100M for New Emergency Department at Jackson Memorial Hospital
Jackson Health Foundation has secured $100 million to fund a new 178,000‑square‑foot emergency department at Jackson Memorial Hospital in Miami, slated to open on April 23. The fundraising milestone supports expanded emergency services for the region.
Nula Therapeutics Secures $10M Series A From Apollo Health Ventures and $20M ARPA‑H Grant
New York‑based biotech startup Nula Therapeutics announced it has raised $10 million in a Series A round led by Apollo Health Ventures, alongside a $20 million grant from the U.S. Advanced Research Projects Agency for Health (ARPA‑H) to study aging. The funding will...
Roche to Acquire SAGA Diagnostics for Up to $595M
Roche announced a definitive merger agreement to acquire SAGA Diagnostics, the developer of the Pathlight tumor‑informed MRD platform, for up to $595 million, including milestone payments. The acquisition will integrate SAGA’s platform into Foundation Medicine’s portfolio, expanding Roche’s cancer monitoring capabilities....
MeiraGTx Reacquires Bota‑vec Gene Therapy Rights From Johnson & Johnson for $25M
MeiraGTx announced it is buying back the rights to its bota‑vec gene therapy for X‑linked retinitis pigmentosa from Johnson & Johnson, paying $25 million upfront with a future milestone and royalties. The deal follows a failed Phase 3 trial but MeiraGTx believes...
Joyful Health Secures $17M Series A Funding to Build Unified Financial Infrastructure
Joyful Health announced a $17M Series A round, bringing its total funding to $22M. The round, led by an undisclosed major venture firm, will support the company's AI-driven platform that unifies fragmented healthcare financial systems.
CareDx to Divest Lab Products Unit to EuroBio Scientific for $170M
CareDx has signed a definitive agreement to sell its Lab Products business, which includes PCR and NGS-based transplant diagnostics, to EuroBio Scientific for $170 million in cash. The transaction is expected to close by Q3 2026 and will allow CareDx to focus...
STORM Therapeutics Raises $56M Series C to Advance RNA-Modification Cancer Therapy
Cambridge-based biotech STORM Therapeutics announced a €47.5 million ($56 million) Series C round from existing investors including M Ventures, Pfizer Ventures, Taiho Ventures, IP Group, UTokyo Innovation Platform and Fast Track Initiative. The funding will support the Phase 2 trial...
Worki Raises $2.75M Pre‑seed Round Led by Redesign Health and Healthliant Ventures
Worki, a healthcare workforce infrastructure startup, announced a $2.75 million pre‑seed funding round led by Redesign Health and Healthliant Ventures. The capital will support its AI‑native platform that unifies workforce data across hospital systems. Worki already has deployments with Tanner Health...
Meiji Seika Pharma Invests in Centivax to Develop Universal Influenza Vaccine
Japanese pharmaceutical company Meiji Seika Pharma announced an investment in US biotech Centivax to advance its universal influenza vaccine candidate, Centi-Flu 01, currently in Phase I testing. The amount was not disclosed. The investment aims to accelerate development of a...
Keebler Health Secures $16M Series A Funding Led by Flare Capital Partners
Keebler Health, an AI‑enabled risk adjustment platform, announced a $16 million Series A round led by Flare Capital Partners with participation from Sands Capital, Hustle Fund, Everywhere Ventures, Freestyle Capital, Underdog Labs, Tweener Fund, New Stack Ventures, Tau Ventures, Aviano Ventures and...
Vivos Therapeutics Secures $100M Term Loan Facility Amendment, Draws $60M
Vivos Therapeutics Inc announced that its term loan facility was amended in January 2026, raising the commitment to $100 million and drawing $60 million at closing, with the maturity extended to 2031. The amendment provides additional non‑dilutive capital to support its 2026...
Biogen to Acquire Apellis in $5.6B Buyout
Biogen announced a $5.6 billion acquisition of Apellis, expanding its portfolio beyond neurology. The deal was detailed in a recent filing, confirming the transaction is set to close. The acquisition positions Biogen in new therapeutic areas.
Osteoboost Health Closes $8M Funding Round Led by Ambit Health Ventures
Osteoboost Health announced the close of an $8 million financing round led by Ambit Health Ventures, with participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures and Portfolia. The funds will support the company's FDA-cleared wearable bone-density device and...
Rubicon Research Acquires 85% Stake in Arinna Lifesciences for $21M
Rubicon Research Limited announced the acquisition of an 85% equity stake in Ahmedabad‑based Arinna Lifesciences Limited for approximately ₹176 crore ($21 million), valuing the target at ₹200 crore. The deal gives Rubicon access to Arinna’s domestic sales and distribution network in the CNS...
Stereotaxis to Acquire Robocath for up to $45M
Stereotaxis announced it will acquire French surgical‑robotics firm Robocath for up to $45 million, with $20 million paid upfront and up to $25 million in milestone payments. The acquisition combines complementary robotic technologies for endovascular procedures and is expected to close in mid‑2026.
CPIhealth Acquires Midwest Interventional Spine Specialists and Serenity Surgical Center
CPIhealth, a US‑based interventional pain management platform backed by Iron Path, announced the acquisition of Midwest Interventional Spine Specialists and Serenity Surgical Center. The deal expands CPIhealth’s network of pain‑management providers across the Midwest. Financial terms were not disclosed.
Sonire Therapeutics Raises $18M Series A to Advance Pancreatic Cancer HIFU Therapy
Sonire Therapeutics, a clinical-stage medical device company, announced an $18 million Series A round led by Santé Ventures with participation from Fast Track Initiative, Nomura SPARX Investment and SBI Investment. The funding will support the SUNRISE‑I trial and expansion of its HIFU...
DHL Group Acquires CRYOPDP to Strengthen Pharma Logistics
DHL Group announced the acquisition of CRYOPDP, a specialty courier focused on clinical trials, biopharma and cell and gene therapies, as part of its multi‑billion‑euro investment to expand its life‑sciences logistics network. The deal adds CRYOPDP’s expertise to DHL’s new...
Wavelet Medical Raises $7M Seed Round with Aegis Ventures
Wavelet Medical, an AI‑powered fetal brain monitoring startup spun out of Yale, announced a $7 million seed round and a co‑creation partnership with venture studio Aegis Ventures. The funding will accelerate development and global commercialization of its non‑invasive fetal EEG platform,...
NorthBay Health to Acquire Queen of the Valley Medical Center in Definitive Agreement
Providence announced a definitive agreement for NorthBay Health to acquire the nonprofit Queen of the Valley Medical Center in Napa Valley. No financial terms were disclosed, and the transaction is expected to close by the end of 2026 pending regulatory...
Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharmaceuticals Ltd., an Australian cancer drugmaker, raised $600 million via a convertible bond offering, up from its original $550 million target. The bonds were priced at a $13.85 conversion price, a 37.5% premium, reflecting strong investor demand.
Eli Lilly to Acquire CrossBridge Bio for up to $300M
Eli Lilly announced on Tuesday it will acquire cancer‑focused antibody‑drug conjugate startup CrossBridge Bio for up to $300 million. The deal, involving biotech entrepreneur Michael Torres, aims to strengthen Lilly’s oncology pipeline. The acquisition was disclosed on 14 April 2026.
American Industrial Partners to Acquire Avanos Medical in $1.272B Take Private Deal
American Industrial Partners' affiliates have signed a definitive agreement to acquire Avanos Medical in an all‑cash transaction valued at approximately $1.272 billion. Avanos shareholders will receive $25 per share, a 72.1% premium, and the company will be taken private and delisted...
Harbinger Health Raises $100M to Advance Cancer Detection Technology
Harbinger Health, a startup developing cancer‑detection tests, announced a $100 million financing round to accelerate its technology. The funding will support further development and commercialization of its cancer‑detection platform. The round was announced on April 14, 2026.
GE HealthCare Acquires Intelerad for $2.3B
GE HealthCare completed the acquisition of Montreal‑based Intelerad in a cash transaction valued at $2.3 billion, expanding its cloud‑first, AI‑enabled imaging business and strengthening its presence in specialized clinics and ambulatory care.
Quiver Bioscience Secures Strategic Investment From Porta Family
Quiver Bioscience announced a targeted strategic investment from the Porta family to fund its Argentina office and advance its antisense oligonucleotide program for Dup15q syndrome. The funding will support pre‑clinical safety studies and candidate selection on the path toward clinical...
Remission Medical Closes Series A Financing Led by Blue Heron Capital
Remission Medical, a virtual rheumatology company, announced the close of its Series A funding round led by Blue Heron Capital. The capital will fund expansion of its partner network, growth of its clinical workforce, and scaling of infrastructure to deliver...
Private Equity Firm Acquires 5-Building, 506-Bed Skilled Nursing Portfolio in Oklahoma
Plains Commercial Real Estate announced the sale of a five-building, 506-bed skilled nursing facility portfolio in Oklahoma to a Northeast-based private equity firm. The buyer, an existing investor in the skilled nursing sector, acquired the assets from a second-generation operator...
Stryker to Acquire Amplitude Vascular Systems, Expanding IVL Portfolio
Stryker announced an agreement to acquire Boston‑based Amplitude Vascular Systems, the maker of the Pulse IVL platform. The terms were undisclosed and the deal remains subject to customary closing conditions. The acquisition broadens Stryker’s peripheral vascular offerings and positions it...
MKH Capital Acquires Haven Health Management
Private equity firm MKH Capital announced the acquisition of Haven Health Management, adding 22 behavioral health facilities to its portfolio and expanding its footprint across the United States and Puerto Rico. The deal, reported on April 13, 2026, did not...
Sterling Acquires Healthcare Linen Services Group From York Private Equity
Sterling announced the acquisition of Healthcare Linen Services Group, previously owned by York Private Equity. The deal was announced on April 10, 2026, marking Sterling's expansion into the healthcare linen services market. Deal value was not disclosed.
Oricell Therapeutics Raises $110M in Pre-IPO Financing
Oricell Therapeutics, a China-based developer of CAR‑T therapies for solid tumors, announced it has raised over $110 million in a pre‑IPO financing round. The capital will fund the advancement of its GPC3‑targeted autologous CAR‑T program and support the company's planned public...
Manulife Canada Pledges $730k to Launch Quebec's First Dementia Prevention Clinic
Manulife Canada has pledged $730,000 over four years to establish the Douglas Cognitive Health and Prevention Clinic at the Douglas Mental Health University Institute, aiming to provide precision‑medicine dementia prevention for adults 40+. The clinic will serve as a model...
LivTech Acquires Alora Healthcare Systems to Expand Post-Acute Care Platform
LivTech, a healthcare‑tech provider for long‑term post‑acute care, has completed the acquisition of Alora Healthcare Systems, a cloud‑based AI‑enhanced home‑health software developer. Backed by growth‑equity firm PSG, the deal integrates Alora’s AI‑powered EMR into LivTech’s platform, expanding its post‑acute care...
GTCR Completes Acquisition of Zentiva From Advent
Private equity firm GTCR has completed its acquisition of European generics pharmaceutical company Zentiva, buying it from Advent. The deal was announced on April 9, 2026, marking GTCR's entry into the generics market. Deal value was not disclosed.
Boehringer Ingelheim Invests $50M in Click Therapeutics to Commercialize CT‑155 Schizophrenia Digital Therapeutic
Boehringer Ingelheim has made a $50 million Series D strategic investment in Click Therapeutics, transferring all commercial and marketing rights for the CT‑155 digital therapeutic targeting negative symptoms of schizophrenia. The funding will support commercialization and includes undisclosed dedicated commercial funding. The...
Avalyn Pharma Files for IPO to Fund Pulmonary Fibrosis Treatments
Avalyn Pharma, a biotech developing inhaled formulations of approved pulmonary fibrosis drugs, announced it has filed for an initial public offering. The company aims to raise capital to fund its late-stage development work and bring its treatments to market.
Basilea Pharmaceutica Secures $6M Non‑dilutive Grant From CARB‑X for Novel Antibiotic BAL2420
Swiss biotech Basilea Pharmaceutica announced it has received an additional US$6 million non‑dilutive grant from the non‑profit accelerator CARB‑X to fund the Phase I trial of its novel Gram‑negative antibiotic BAL2420. The funding follows six years of CARB‑X support and enables the...
Orlando Health to Acquire RMC Health System
Orlando Health announced an agreement to acquire Anniston‑based nonprofit RMC Health, expanding its presence in Alabama. The undisclosed‑value deal is expected to close in the fall pending regulatory approvals. This follows Orlando Health’s prior Alabama acquisitions, including Baptist Health for...
ReAlta Life Sciences Secures $40M in Oversubscribed Financing
ReAlta Life Sciences Inc., a clinical-stage biopharma focused on neutrophil and complement system therapies, announced the closing of an oversubscribed $40 million financing, bringing its total capital raised to over $150 million. The round was completed on April 8, 2026, marking a significant funding...
Max Healthcare Acquires 58.4% Controlling Stake in Kalinga Hospital for $36.6M
Max Healthcare has entered a share purchase agreement to acquire a 58.4% controlling stake in Kalinga Hospital Limited from Hospital Corporation of Orissa for an equity value of $36.6M. The deal expands Max's footprint in eastern India, adding a 250‑bed...
Gilead to Acquire Tubulis for ~$5B
Gilead has entered into a definitive agreement to acquire Tubulis, an ADC research organization, for an upfront $3.15B plus up to $1.85B in contingent milestone payments, totaling roughly $5B. The acquisition will expand Gilead’s ADC capabilities and add next‑generation assets...